The J.M. Smucker Company stocks have been trading up by 9.61 percent after upbeat earnings and guidance lifted investor confidence
Key Takeaways
- UBS trimmed its J.M. Smucker price target to $121 from $132 but kept a Buy rating, still seeing organic growth and strong profit delivery over the next 12–18 months.
- Morgan Stanley nudged its J.M. Smucker target to $106 from $104, kept Equal Weight, yet calls SJM the best-screening name in its group with the lowest earnings revision risk.
- RBC expects fiscal Q4 and 2027 guidance from J.M. Smucker to land roughly in line, backing an Outperform rating and a $130 target versus a share price near $102.50.
- Street stance on SJM remains overweight, with average targets in the mid‑$116 range while the stock has been trading just above $100, suggesting room for a re‑rating.
- Consensus for J.M. Smucker’s upcoming fiscal Q4 print sits at $2.64 EPS before the next market open, setting a clear line for traders to watch.
Live Update At 14:32:53 EDT: On Tuesday, June 09, 2026 The J.M. Smucker Company stock [NYSE: SJM] is trending up by 9.61%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
SJM has quietly put together a sharp bounce on the chart. After closing near $100 in late May 2026, The J.M. Smucker Company ripped to a recent high above $115 on 2026/06/09 before settling near $111.62. That’s a strong short-term uptrend, with higher highs and higher lows across the last several sessions.
Intraday action shows tight, controlled trading. On the latest day, SJM opened at $106.96, flushed to $105.50, then steadily climbed through the morning, touching $115.23 by late morning and grinding around $112 into the afternoon. That intraday pattern—early shakeout, strong trend, then consolidation—often shows real demand rather than random noise.
More Breaking News
- AZI Stock Explodes Higher As Volatility Grips Traders
- BCDA Stock Surges As FDA Softens Trial Requirements For CardiAMP
- BTBT Stock Tests Lows As Ethereum And AI Bet Expands
- LASE Stock Rockets As Anti‑Drone Win Fuels Defense Momentum
Fundamentally, J.M. Smucker is a cash machine even while headline earnings look weak. Revenue runs around $8.73B annually with a solid 33.6% gross margin. Net profit margins are negative right now, largely due to a heavy impairment charge that pushed reported net income to about -$724.2M in the latest quarter. But operating cash flow of $558.5M and free cash flow of $487M tell a different story: SJM is still generating real cash, paying a dividend around 4.3%, and managing a leveraged but workable balance sheet. For traders, that mix—chart strength with beaten‑up optics—often sets up mispriced moves.
Why Traders Are Watching SJM Into Earnings
SJM is back on momentum screens because the stock is moving while Wall Street quietly leans bullish. UBS cut its J.M. Smucker price target to $121 from $132 on 2026/06/02, acknowledging softer packaged‑food demand and sticky inflation. But the key for traders is what they did not change: the Buy rating and the view that J.M. Smucker still has a “credible path” to organic sales growth and strong bottom-line results over the next 12–18 months. That’s exactly the kind of language momentum traders like to see behind a breakout.
RBC Capital added fuel on 2026/06/05. The firm expects SJM’s fiscal Q4 results and 2027 guidance to come in broadly in line. They highlight strength in coffee, weaker trends in pet, and mixed performance in frozen handhelds and spreads. Even with that uneven mix, RBC stuck with an Outperform and a $130 target, calling for upside from a share price near $102.50. That gives traders a clear narrative: coffee is the workhorse; pet and frozen are the drag.
Morgan Stanley, often more cautious, still raised its J.M. Smucker target to $106 from $104 and labeled SJM the “least revision risk” name in its group, even while trimming 2027 EPS estimates and keeping an Equal Weight rating. When the more skeptical shop calls J.M. Smucker the best‑screening name, traders pay attention. Across the Street, average targets in the mid‑$116 range versus a recent price around $100–$112 signal that SJM is trading at a discount to analyst models.
Now add the near‑term catalyst. Wall Street is looking for J.M. Smucker to deliver $2.64 in fiscal Q4 EPS before the next open. For short‑term traders, that single number—and management’s 2027 outlook—will likely decide whether SJM continues its push toward those $116–$130 targets or snaps back into the low $100s. This is classic event‑driven trading terrain.
Conclusion
For active traders, SJM is a slow‑and‑steady staple name behaving like a momentum play. The J.M. Smucker Company just broke out from a tight base near $100 and sprinted to the mid‑$110s, all while the Street marked up or only modestly trimmed price targets. UBS still sees SJM at $121 with a Buy, RBC is out at $130 with an Outperform call, and consensus hovers in the mid‑$116 range. That is firm support behind the tape.
At the same time, the fundamentals show why J.M. Smucker is tricky but tradable. Heavy impairment charges and leverage push reported margins and returns deep into the red, yet SJM generates hefty free cash flow and funds a dividend yield above 4%. Coffee strength offsets weaker pet and mixed frozen categories. Earnings at $2.64 EPS are the next hurdle, and the market will grade the 2027 roadmap just as hard as the headline number.
For traders who study charts and catalysts, SJM fits the rule‑based playbook that Tim Sykes and his community preach—focus on clear patterns, hot news, and defined risk. As Tim likes to hammer home, “Trade like a sniper, not a machine gun. Wait for the best setups, strike fast, and always respect your risk.” As millionaire penny stock trader and teacher Tim Sykes, says, “Cut losses quickly, let profits ride, and don’t overtrade.”. SJM’s setup around this earnings release is not a guarantee in any direction, but it is a clean, high‑information event. Manage your plan, watch the levels, and let the price action confirm the story.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



Leave a reply